In this regard, high expression of p300 (refs 57, 58) as well as Ubc9 (ref. 59) in clinical HCC samples may partially explain the phenotype of low PEPCK1 expression through enhanced sumoylation modification. This evidence concerns the gene PCK1 and hepatocellular carcinoma.